We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...

The multinational survey provides valuable insights into public perceptions of innovation and the challenges obstructing progress. For instance, around three in four respondents (71%) believe ...

Philip Morris International Inc. (PM) stock saw a modest uptick, ending the day at $121.59 which represents a slight increase of $1.79 or 1.49% from the prior close of $119.8. The stock opened at $119 ...

Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...

Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...

We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...

Philip Morris International Inc. closed $16.60 below its 52-week high ($134.15), which the company reached on October 31st.

First Hawaiian Bank decreased its position in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by 4.8% ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this move aligns with its long-term strategy.

Philip Morris International Inc. (PM) stock saw a decline, ending the day at $117.15 which represents a decrease of $-4.71 or -3.87% from the prior close of $121.86. The stock opened at $119.96 and ...